TRANSACTION RECORD

DOWNLOAD RECORD   vCard | CSV | PDF
Company Name TCR2 Therapeutics
Status Publicly-held
Industry Biopharmaceutical
Company Description TCR2, Inc. (Nasdaq: TCRR) is a pharmaceutical company focused on engineering T cells for cancer therapy.
Mailing Address 100 Binney St. Suite 710
Cambridge, MA 02142
USA  Map
Phone (617) 949-5200
Website www.tcr2.com
Email Click for Free Trial
Profile
Social Media
Company News
Facebook
YouTube
 
Company Management
Title Name Email Profile
     
Chief Executive Officer Menzel, Garry
Chief Financial Officer Somaiya, Ian
Chief Scientific Officer Hofmeister, Robert
Chief Medical Officer Cardama, Alfonso
VP - Bus. Development Cornforth, Andrew
VP - Operations Lynch, Amy
VP - R & D Getts, Daniel
Information Release Date 12/31/2015
Transaction Type Venture Equity
Amount $5,800,000
Round Undisclosed
Proceeds Purposes Proceeds purposes were not disclosed.
Transaction Investors
MPM Capital
Undisclosed

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.


PCI - Level1